BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 17365228)

  • 1. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Fieller-Hinkley distribution of the ratio of random variables in testing for noninferiority.
    Koti KM
    J Biopharm Stat; 2007; 17(2):215-28. PubMed ID: 17365219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tests for null hypothesis of non unity ratio of proportions.
    Koti KM
    J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple testing of noninferiority hypotheses in active controlled trials.
    Hung HM; Wang SJ
    J Biopharm Stat; 2004 May; 14(2):327-35. PubMed ID: 15206530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous testing of noninferiority and superiority increases the false discovery rate.
    Ng TH
    J Biopharm Stat; 2007; 17(2):259-64. PubMed ID: 17365222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adjustment of the type I error rate in noninferiority trials with λ-margin approach: each of two different new drugs is approved with two independent trials with the same active control.
    Kang SH; Ryu Y
    J Biopharm Stat; 2011 May; 21(3):498-510. PubMed ID: 21442522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E; Tango T
    J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covariate effect on constancy assumption in noninferiority clinical trials.
    Xu S; Barker K; Menon S; D'Agostino RB
    J Biopharm Stat; 2014; 24(6):1173-89. PubMed ID: 25036666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On non-inferiority margin and statistical tests in active control trials.
    Chow SC; Shao J
    Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note on partial covariate-adjustment and design considerations in noninferiority trials when patient-level data are not available.
    Nie L; Soon GG; Qi K; Chen Y; Chu H
    J Biopharm Stat; 2013; 23(5):1042-53. PubMed ID: 23957514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
    Tsong Y; Wang SJ; Hung HM; Cui L
    J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.